Generics News
-
Generics will lead to $7 bn loss for statins market
Generics | News | By BioSpectrum Bureau | 0 Comment | 31 Jan, 2013
Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the globa...Read more
-
Sun Pharma's founder named India's 3rd richest
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Oct, 2013
Singapore: For the first time, founder of leading Indian drugmaker Sun Pharmaceuticals, Mr Dilip Shanghvi has been named...Read more
-
Mylan launches generic of Pfizer's antifungal drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2013
Singapore: US-based Mylan Pharmaceuticals has launched generic version of Pfizer's Vfend, Voriconazole for Oral Suspensi...Read more
-
Cipla wins patent case against Roche
Generics | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Bangalore: India's generics giant Cipla has won a landmark patent case against Swiss drug maker Roche in the Delhi High ...Read more
-
Sun Pharma registers Rs 1391 crores profit in Q1
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2014
Singapore: Posting a net profit of Rs 1391 crores in Q1, Sun Pharma exhibited a flat growth in line with the market expe...Read more
-
Teva patent request rejected by US Supreme Court
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2013
Singapore: The US Supreme Court declined a request from Teva Pharmaceutical for a stay of an appeals court ruling that w...Read more
-
Daiichi Sankyo seeks approval for TB drug in Japan
Generics | News | By BioSpectrum Bureau | 0 Comment | 06 Oct, 2014
Singapore: Daiichi Sankyo's generic subsidiary, Daiichi Sankyo Espha has submitted a supplemental New Drug Application (...Read more
-
Aurobindo to acquire Actavis generics unit in EU
Generics | News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2014
Mumbai: India-based Aurobindo Pharma intends to acquire Actavis' generics commercial operations in seven markets in West...Read more
-
Ranbaxy sues Actavis to stop acne generic sale
Generics | News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2013
Singapore: Dublin headquartered generic drugmaker Actavis has now been caught in a legal tangle after Indian drug major ...Read more
-
IPAB revokes patent for GSK's anti-cancer drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013
New Delhi: In yet another blow to multinational companies operating in India, the Intellectual Property Appellate Board ...Read more
-
TWi appoints new CEO to boost US market
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Mar, 2015
Singapore: Taiwan based TWi Pharmaceuticals has appointed Ms Tina Guilder as President and CEO and Ms Eva Ho as CFO to s...Read more
-
German firm buys $200 mn stake in Indian generic company
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2013
Singapore: Gland Pharma, a leading Indian pure-play generic injectable pharmaceutical products company, has signed an ag...Read more
-
Biocon: A nesting ground for biotech spinoffs
Generics | Analysis | By BioSpectrum Bureau | 3 Comment | 16 May, 2014
It has added one more feather to its cap by being the nesting ground to churn out new start-ups. It is an informal incub...Read more
-
FAPA: Indian pharma to fatten in biosimilars era
Generics | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2014
Singapore: The Federation of Asian Pharmaceuticals Association (FAPA) said that the upcoming patent cliff will be advant...Read more
-
Celltrion files an FDA application for biosimilar
Generics | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2014
Singapore: With biosimilars promising an exponential growth, South Korea's Celltrion has filed an FDA application for Re...Read more
-
Wockhardt's third Indian plant faces export ban
Generics | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2013
Singapore: Britain's drug regulator, the UK Medicines and Healthcare Products Regulatory Agency has revoked the quality ...Read more
-
Cipla appoints Subhanu Saxena as CEO
Generics | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2012
Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxe...Read more
-
Cipla divests its stake from a Chinese firm
Generics | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014
Singapore: Indian pharma major, Cipla recently announced that the company's wholly owned subsidiary Meditab holdings ent...Read more
